title: In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS.
abstract: In vitro susceptibilities of Mycoplasma penetrans were determined. MICs and MBCs were determined. The MICs at which 50% of the isolates are inhibited (micrograms per milliliter) for broth dilution testing were as follows: azithromycin, 0.039; chloramphenicol, 0.625; ciprofloxacin, 0.156; clindamycin, 0.078; doxycycline, 0.312; erythromycin, 0.312; gentamicin. > 10; levofloxacin, 0.078; lincomycin, 0.625; streptomycin, > 10; and tetracycline, 1.25. Bactericidal activity was significant only for ciprofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml) and levofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml).
authors.affiliation: Department of Infectious and Parasitic Disease Pathology, Armed Forces Institute of Pathology, Washington, D.C. 20306-6000, USA.
authors.forename: M M
authors.initials: MM
authors.lastname: Hayes
authors.forename: H H
authors.initials: HH
authors.lastname: Foo
authors.forename: J
authors.initials: J
authors.lastname: Timenetsky
authors.forename: S C
authors.initials: SC
authors.lastname: Lo
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009175:Mycoplasma Infections / Q000150:complications / Q000188:drug therapy; D018661:Mycoplasma penetrans / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents